Apellis Pharmaceuticals, Inc. — DEFA14A Filings
8 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Apellis Pharmaceuticals, Inc. (APLS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apellis Pharmaceuticals, Inc. has filed 8 DEFA14A documents with the SEC since 2019. To view all SEC filings by Apellis Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0000950170-25-056967 | Apr 23, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-24-049107 | Apr 26, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-23-013763 | Apr 21, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-111107 | Apr 20, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-21-126701 | Apr 22, 2021 | — |
| DEFA14A | DEFA14A | 0001193125-20-115084 | Apr 22, 2020 | — |
| DEFA14A | DEFA14A | 0001193125-19-127354 | Apr 30, 2019 | — |
| DEFA14A | DEFA14A | 0001193125-18-130567 | Apr 25, 2018 | — |